ISB News

Aitchison Lab Accepts ALS Ice Bucket Challenge

Jennifer Smith, senior research scientist in the John Aitchison Lab, was tagged to do the ALS Ice Bucket Challenge. And because the Aitchison group studies ALS, Jennifer’s lab mates took the challenge, too. Jennifer offered this description of the work they are doing to create a blood test for early detection of ALS:

ISB is developing a multi-component blood-based assay (blood test) for early detection and disease tracking of ALS. We are doing this because there are no good diagnostic tests for ALS and, on average, it takes a year to get a definitive diagnosis, resulting in significant loss of therapeutic opportunity. There is a dire need for a robust and quantitative blood biomarker assay to help confirm initial diagnosis of ALS and to track disease activity not only for clinical use, but to also to develop new therapies for the disease.

The assay we are developing is called the indicator cell assay platform (iCAP) for blood-based diagnostics that can be used for early detection of ALS, and as a diagnostic tool for drug development. The iCAP uses cultured cells as biosensors, capitalizing on the natural ability of cells to detect signals present in serum from patients with ALS with exquisite sensitivity, as opposed to traditional assays that rely on direct detection of molecules in blood.

You can support ALSA.org to raise awareness about ALS. Or you can support ALS research directly with a gift to Institute for Systems Biology. Support ALS research directly.

You Have 24 Hours to Accept the Challenge!

And now, the Aitchison Lab challenges the following groups:

  • Mike Rout Lab, The Rockefeller University
  • Alan Aderem Lab, Seattle BioMed
  • Dave Goodlett Lab, University of Maryland

Learn more about the Aitchison Lab and Jennifer Smith. Jennifer received a “proof of concept” grant from the Life Sciences Discovery Fund to develop a similar early detection test for Alzheimer’s.

Ice Bucket Challenge Photo Gallery

You may also visit the full gallery on Flickr.

ALS5614 ALS5615 ALS5616

Recent Articles

  • COVID-19 Vaccines and Boosters Are Essential for Maternal-Fetal Health

    In light of the recent FDA and CDC decision to approve two updated messenger RNA COVID-19 booster shots, it is imperative to alert the pregnant population of the importance and effectiveness of these vaccines and boosters. 

  • Spotlight on ISB Education graphic

    2022-23 School Year ISB Education Highlights

    From planning, creating and executing workshops for educators to forging new relationships to elevate students, the ISB Education team has been in high gear. Each month throughout the 2022-2023 academic year, we will highlight some of the top projects the team is working on.

  • 2023 ISB Virtual Microbiome Series

    2023 ISB Virtual Microbiome Series Registration Now Open!

    On October 11-13, 2023, ISB will host a virtual course and symposium on how the ecology of our guts protects us from pathogens. Both events are virtual and free. The intended audience for these events are graduate students, postdocs, principal investigators, industry scientists, educators, clinicians, or any other variety of microbiome-curious person from across the globe.